Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.ZOM · Entity 6884 | Director · President and CEO · 10% owner | March 29, 2019 | April 02, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date March 29, 2019 · Filed April 02, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, without par valueSEC Table I · non-derivative | Direct | 38,545,671 |
Reported balance
After 2019-03-29 transaction · row 1
1 source rowRow 1 · 2019-03-29 · Exercise / conversion · Acquired 65,789 · Balance 38,545,671 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.52 · Expires 2021-01-10 | Direct | 1,705,265 |
Reported balance
After 2019-03-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-29 · Exercise / conversion · Disposed 65,789 · Balance 1,705,265 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2019 Filed Apr 2, 2019 16:01 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 65,789 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-002177 · ownership.xml · derivative · entry 2 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,705,265 Underlying: Common Shares, without par value · 65,789 shares Expires 2021-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 16:01 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 65,789 | $1.52 | $99,999.28 |
DisclosureSEC source: 0001171843-19-002177 · ownership.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,545,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 16:01 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 164,473 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-001790 · ownership.xml · derivative · entry 2 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,771,054 Underlying: Common Shares, without par value · 164,473 shares Expires 2021-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 16:01 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 164,473 | $1.52 | $249,998.96 |
DisclosureSEC source: 0001171843-19-001790 · ownership.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,479,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 16:06 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 164,473 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-001650 · ownership.xml · derivative · entry 2 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,935,527 Underlying: Common Shares, without par value · 164,473 shares Expires 2021-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 16:06 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 164,473 | $1.52 | $249,998.96 |
DisclosureSEC source: 0001171843-19-001650 · ownership.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,315,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 16:12 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 2,100,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000263 · ownership.xml · derivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,100,000 Underlying: Common Shares, without par value · 2,100,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| October 11, 2018 Filed Oct 12, 2018 18:56 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000845 · ownership.xml · derivative · entry 2 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 200,000 shares Expires 2018-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. Read SEC document |
| October 11, 2018 Filed Oct 12, 2018 18:56 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 200,000 | $1.20 | $240,000.00 |
DisclosureSEC source: 0000905718-18-000845 · ownership.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,151,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2018 Filed Mar 12, 2019 16:03 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 164 | $1.89 | $309.96 |
DisclosureSEC source: 0001171843-19-001649 · ownership.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,950,936 F1 · date: The transfer of 164 Common Shares to SEI Private Trust Company on October 2, 2018 was inadvertently omitted from the Form 4 filed by Reporting Person on October 12, 2018. The 164 Common Shares were transferred without Reporting Person's consent and the transfer is currently being contested by Reporting Person. Read SEC document |
| December 19, 2017 Filed Dec 19, 2017 19:36 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 750,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0000905718-17-001034 · zomed_fm4solen12192017.xml · derivative · entry 2 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Shares, without par value · 750,000 shares Expires 2018-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| December 19, 2017 Filed Dec 19, 2017 19:36 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 750,000 | $1.20 | $900,000.00 |
DisclosureSEC source: 0000905718-17-001034 · zomed_fm4solen12192017.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,951,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.